News und Analysen

Pfizer's (NYSE: PFE) shares have been southbound for the better part of three years, partly because it was unable to repeat its incredible financial performance during the early pandemic years

Palantir Technologies (NASDAQ: PLTR) stock has returned 910% since the inception of the artificial intelligence boom in late 2022, and the company is currently worth $200 billion. But some Wall

Shares of IonQ (NYSE: IONQ) are surging this week. The company's stock had gained 25% over the week as I write this. The strong performance easily outpaced the S&P 500's most chaotic week in years.

After back-to-back years of strong returns for cruise line stocks, this year has been enough to make investors seasick. The three largest cruise line operators are trading 29%, 17%, and 35% lower in

There's a lot of uncertainty in the stock market and the U.S. economy right now, and that's probably putting it lightly. As the Trump administration implements new tariffs, businesses and consumers

As the stock market swings wildly thanks to erratic, unpredictable, and potentially economically damaging tariff policies from the Trump administration, predicting anything in the near term about

The stock market is off to a rough start to 2025. It's never fun to see the value of your portfolio dwindle, and there's never any certainty about when a period of market volatility will end. But

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is even

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the

In today's video, I discuss Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and recent updates impacting the semiconductor market. To learn more, check out the short video, consider

In today's video, I discuss Broadcom (NASDAQ: AVGO), Advanced Micro Devices (NASDAQ: AMD), and Taiwan Semiconductor Manufacturing (NYSE: TSM). To learn more, check out the short video, consider

Viking Therapeutics (NASDAQ: VKTX) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects.

This year

Roughly four out of five S&P 500 (SNPINDEX: ^GSPC) stocks are in negative territory in 2025. Most of those stocks weren't immune to the meltdown that occurred in recent days following President

Explore the exciting world of Advanced Micro Devices (NASDAQ: AMD) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Just like the rest of the stock market, pharmaceutical stocks are in a funk approaching the midweek mark, and it's looking like things might be about to get even worse for this particular pocket of

Congress recently confirmed President Donald Trump's pick, Dr. Mehmet Oz, to lead the Centers for Medicare and Medicaid Services (CMS). Medicare and Medicaid provide healthcare insurance to an

With equity markets in shambles due to President Donald Trump's trade policies, now might be as good a time as any to invest in excellent dividend stocks.

For one, dividend-paying companies tend to

From TV star to powerful government official. That's the path taken by President Donald Trump and his new administrator of the Centers for Medicare and Medicaid Services (CMS) -- Dr. Mehmet Oz.

Oz

If you're a dividend investor, now can be an ideal time to go bargain-hunting. The stock market is in the midst of a broad sell-off, with investors dumping all types of stocks, both bad ones and

Don't let the sell-off in the markets scare you off: Now may be an ideal time to buy stocks. Even if you don't have a lot of money that you can afford to invest, there are many great stocks you can

The Dow Jones Industrial Average (DJINDICES: ^DJI) fell sharply after the U.S. released a new tariff program. Does that open up some opportunities for investors who like high-yield stocks? A quick